UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

Journal of neuro-oncology, 2015-04, Vol.122 (2), p.367-382

2015

Volltextzugriff (PDF)

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Journal of clinical oncology, 2023-01, Vol.41 (3), p.618-628

2023

Volltextzugriff (PDF)

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients

Cancer, 2024-05, Vol.130 (9), p.1577-1589

2024

Volltextzugriff (PDF)

Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)

Journal of neuro-oncology, 2019-09, Vol.144 (2), p.303-311

2019

Volltextzugriff (PDF)

In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma

Cancers, 2023-06, Vol.15 (13), p.3289

2023

Volltextzugriff (PDF)

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma

Scientific reports, 2019-07, Vol.9 (1), p.10861-7, Article 10861

2019

Volltextzugriff (PDF)

Older age at the completion of linear growth is associated with an increased risk of adult glioma

Cancer causes & control, 2017-07, Vol.28 (7), p.709-718

2017

Volltextzugriff (PDF)

Analgesic use and the risk of primary adult brain tumor

European journal of epidemiology, 2016-09, Vol.31 (9), p.917-925

2016

Volltextzugriff (PDF)

Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma

Cancer causes & control, 2017-07, Vol.28 (7), p.717-718

2017

Volltextzugriff (PDF)

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Neuro-oncology (Charlottesville, Va.), 2015-03, Vol.17 (3), p.430-439

2015

Volltextzugriff (PDF)

Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma

Cancer epidemiology, 2018-08, Vol.55, p.45-51

2018

Volltextzugriff (PDF)

Anaplastic astrocytomas: biology and treatment

Expert review of neurotherapeutics, 2008-04, Vol.8 (4), p.575-586

2008

Volltextzugriff (PDF)

MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin-4 receptor (IL4R) as compared to a matched synthetic control

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.2513-2513

2020

Volltextzugriff (PDF)

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.2502-2502

2020

Volltextzugriff (PDF)

Pathologic quiz case: a 5-month-old infant with respiratory distress

Archives of pathology & laboratory medicine (1976), 2003-02, Vol.127 (2), p.E103-e104

2003

Volltextzugriff (PDF)

MDNA55: A locally administered IL4 guided toxin as a targeted treatment for recurrent glioblastoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.2039-2039

2019

Volltextzugriff (PDF)

A phase II study of the combination of BKM120 (buparlisib) and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM)

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.2065-2065

2015

Volltextzugriff (PDF)

Small business technology transfer (STTR) phase I study (1 R41 MD006148-01) of an automated voice response (AVR) system to improve symptom management in neuro-oncology patients

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e12500-e12500

2012

Volltextzugriff (PDF)

Cancer in the Spine: Comprehensive Care

Neuro-oncology (Charlottesville, Va.), 2006-07, Vol.8 (3), p.286-286

2006

Volltextzugriff (PDF)

High-dose methotrexate complicated by acute tubular necrosis

Therapy, 2006-07, Vol.3 (4), p.495-497

2006

Volltextzugriff (PDF)

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

PloS one, 2024-01, Vol.19 (1), p.e0291128

2024

Volltextzugriff (PDF)

Bevacizumab for the treatment of glioblastoma

Expert review of neurotherapeutics, 2013-08, Vol.13 (8), p.937-949

2013

Volltextzugriff (PDF)

Clinical trials of R- in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

PloS one, 2024-01, Vol.19 (1), p.e0291128

2024

Volltextzugriff (PDF)

Clinical trials of R

PloS one, 2024-01, Vol.19 (1), p.e0291128

2024

Volltextzugriff (PDF)

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma

Journal of neuro-oncology, 2012-10, Vol.110 (1), p.111-118

2012

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(55)

Publikationsform

Artikel
(63)
Buchkapitel
(3)

Sprache

Englisch
(66)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Practical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients

Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II)

In Vitro and In Vivo Drug-Response Profiling Using Patient-Derived High-Grade Glioma

Methylmercury exposure, genetic variation in metabolic enzymes, and the risk of glioma

Older age at the completion of linear growth is associated with an increased risk of adult glioma

Analgesic use and the risk of primary adult brain tumor

Erratum to: Older age at the completion of linear growth is associated with an increased risk of adult glioma

Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma

Toenail selenium, genetic variation in selenoenzymes and risk and outcome in glioma

Anaplastic astrocytomas: biology and treatment

MDNA55 survival in recurrent glioblastoma (rGBM) patients expressing the interleukin-4 receptor (IL4R) as compared to a matched synthetic control

Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations

Pathologic quiz case: a 5-month-old infant with respiratory distress

MDNA55: A locally administered IL4 guided toxin as a targeted treatment for recurrent glioblastoma

A phase II study of the combination of BKM120 (buparlisib) and bevacizumab in patients with relapsed/refractory glioblastoma multiforme (GBM)

Small business technology transfer (STTR) phase I study (1 R41 MD006148-01) of an automated voice response (AVR) system to improve symptom management in neuro-oncology patients

Cancer in the Spine: Comprehensive Care

High-dose methotrexate complicated by acute tubular necrosis

Clinical trials of R-(-)-gossypol (AT-101) in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

Bevacizumab for the treatment of glioblastoma

Clinical trials of R- in newly diagnosed and recurrent glioblastoma: NABTT 0602 and NABTT 0702

Clinical trials of R

A prospective phase II single-institution trial of sunitinib for recurrent malignant glioma

Suchergebnisse filtern